Roche CEO Thomas Schinecker said in a statement on Tuesday that the company’s new $50 billion investment demonstrated its ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...

Roche continues to explore Columvi as both a single agent and with other medicines for the treatment of mantle cell lymphoma ...